111 (YI) EBT Margin (2017 - 2025)

111 (YI) posted EBT Margin of 0.23% for Q4 2025, down 377.82% sequentially from 0.05% in Q3 2025, and up 10.0% YoY from 0.21% in Q4 2024.

111 (YI) EBT Margin (2017 - 2025) Analysis & Trends

111 has reported EBT Margin for 9 years, with the latest figure at 0.23% in Q4 2025.

Quarterly EBT Margin rose 10.0% year-over-year to 0.23% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.18% (down 4.0% YoY) and the FY2025 annual result came in at 0.18%, down 4.0% from the prior year.
EBT Margin fell to 0.23% in Q4 2025 per YI's latest filing, from 0.05% in the prior quarter.
Over five years, EBT Margin peaked at 0.05% in Q3 2025 and troughed at 6.53% in Q1 2021.
A 5-year average of 2.11% and a median of 1.79% in 2023 frame the typical range for EBT Margin.
The sharpest annual moves came in 2023 and 2024: EBT Margin tumbled 248 bps in 2023, then jumped 467 bps in 2024.
Over 5 years, EBT Margin stood at 2.95% in 2021, then grew by 15 bps to 2.51% in 2022, then slumped by 99 bps to 4.99% in 2023, then surged by 93 bps to 0.33% in 2024, then rose by 29 bps to 0.23% in 2025.
According to Business Quant data, EBT Margin over the past three periods registered 0.23%, 0.05%, and 0.23% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Mckesson	100.02 Bn	94.85 Bn	3.69 Bn	1.24%
2	Cencora	60.88 Bn	58.06 Bn	3.61 Bn	1.18%
3	Cardinal Health	54.14 Bn	49.29 Bn	2.56 Bn	0.87%
4	Henry Schein	10.05 Bn	9.90 Bn	1.10 Bn	3.96%
5	Akso Health	737.16 Mn	736.96 Mn	-	-
6	Edap Tms	159.12 Mn	137.58 Mn	7.34 Mn	-109.10%
7	Accendra Health	100.85 Mn	93.20 Mn	263.41 Mn	-14.29%
8	111	32.10 Mn	-26.65 Mn	18.18 Mn	-1.14%
9	Cosmos Health	12.73 Mn	10.29 Mn	1.51 Mn	-32.06%
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	-5.99%

Download Data